IDH1-MUTATED MALIGNANCIES
Clinical trials for IDH1-MUTATED MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new IDH1-MUTATED MALIGNANCIES trials appear
Sign up with your email to follow new studies for IDH1-MUTATED MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for cancer patients with organ issues?
Disease control Recruiting nowThis study tests an oral drug called ivosidenib in 30 adults with IDH1-mutated cancers who also have liver or kidney problems. The goal is to see how the drug behaves in the body and if it is safe. Participants take the drug daily in 28-day cycles and have regular blood tests and…
Matched conditions: IDH1-MUTATED MALIGNANCIES
Phase: PHASE1 • Sponsor: Servier Bio-Innovation LLC • Aim: Disease control
Last updated May 26, 2026 09:33 UTC
-
New combo therapy targets tough blood cancers with two gene flaws
Disease control Recruiting nowThis study tests whether combining olutasidenib with other targeted drugs is safe and tolerable for adults with relapsed or hard-to-treat blood cancers (like AML or MDS) that have both an IDH1 mutation and an additional signaling mutation. About 68 participants will receive the d…
Matched conditions: IDH1-MUTATED MALIGNANCIES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 19, 2026 12:00 UTC